Carlson Capital’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,333
| Closed | -$82.6K | – | 145 |
|
|
2022
Q4 | $82.6K | Buy |
2,333
+500
| +27% | +$17.7K | 0.01% | 113 |
|
|
2022
Q3 | $414K | Sell |
1,833
-334
| -15% | -$75.4K | 0.03% | 111 |
|
|
2022
Q2 | $410K | Buy |
2,167
+1,267
| +141% | +$240K | 0.03% | 114 |
|
|
2022
Q1 | $224K | Sell |
900
-1,833
| -67% | -$456K | 0.02% | 145 |
|
|
2021
Q4 | $426K | Buy |
+2,733
| New | +$426K | 0.02% | 134 |
|